IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
1.210
+0.020 (1.68%)
At close: May 7, 2024, 4:00 PM
1.200
-0.010 (-0.83%)
After-hours: May 7, 2024, 7:58 PM EDT
Company Description
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.
It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd
| Country | Israel |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 71 |
| CEO | Eyal Shamir |
Contact Details
Address: 7 Ha'eshel St., Pob 3163 Caesarea, L3 38900 Israel | |
| Phone | 972-4-6230333 |
| Website | icecure-medical.com |
Stock Details
| Ticker Symbol | ICCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001584371 |
| CUSIP Number | M53071136 |
| ISIN Number | IL0011224156 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eyal Shamir | Chief Executive Officer and Director |
| Ronen Tsimerman CPA | Chief Financial Officer and Chief Operating Officer |
| Tlalit Bussi Tel-Tzure | Vice President of Business Development and Global Marketing |
| Merav Nir Dotan | Vice President of Human Resources |
| Galit Malik | Vice President of Operations and Service |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 7, 2024 | 6-K | Report of foreign issuer |
| Apr 15, 2024 | 6-K | Report of foreign issuer |
| Apr 15, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Apr 2, 2024 | 6-K | Report of foreign issuer |
| Mar 19, 2024 | 6-K | Report of foreign issuer |
| Mar 12, 2024 | 6-K | Report of foreign issuer |
| Mar 4, 2024 | 6-K | Report of foreign issuer |
| Feb 26, 2024 | 6-K | Report of foreign issuer |